U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. ITW Dymon - 01/11/2017
  1. Warning Letters

CLOSEOUT LETTER

ITW Dymon

Recipient:
ITW Dymon

United States

Issuing Office:

United States

 

  

Black HHS-Blue FDA Logo

 

 

 
Kansas City District Office
8050 Marshall Drive - Suite 205
Lenexa, Kansas 66214-1524
913-495-5100 

January 11, 2017

VIA UNITED PARCEL SERVICE
CMS CASE 494201

Mr. Paul M. Taylor
Vice President and Group General Manager
ITW PRO Brands
805 E Old 56 Hwy
Olathe, KS 66061

WARNING LETTER CLOSE-OUT LETTER

Dear Mr. Taylor:

The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter, dated October 19, 2016 (CMS Case: 494201). Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action

Sincerely,
/S/

Eric Mueller, Compliance Officer
FDA Kansas City District

Back to Top